Petrovic T, Koller T, Payer J
V interná klinika Lekárskej fakulty UK a FNsP Bratislava-Ruzinov, Slovenská republika.
Vnitr Lek. 2009 Feb;55(2):106-10.
Obesity and venous thromboembolism represent a serious medical problem.
Their mutual relationship was studied on the group of 124 patients with venous thromboembolism (the study group) and was compared to the group of 124 randomly chosen controls among hospitalized patients matched for age, sex and risk factor profile of venous thromboembolism (the control group).
Recorded variables were body weight, presence of arterial hypertension, hypertriglyceridemia and type 2 diabetes or impaired glucose tolerance. We found significantly higher prevalence of obesity--40 vs 23 patients (38.5% vs 23%, p = 0.0283) and significantly higher BMI (29.254 vs 26.923, p = 0.002) in the study group. Increased body weight was found to be the only significant risk factor for venous thromboembolism (odds ratio = 2.507, p = 0.0026) and normal body weight was the only protective factor (odds ratio = 0.3989, p = 0.0026). We equally found the significant increase of the prevalence of venous thromboembolism with increasing body weight (p = 0.020). Even in patients without known risk factors for venous thromboembolism (n = 55) we found significantly higher prevalence of increased body weight (BMI > 25) in the study group (82.4% vs 61.2%, p = 0.0221). No other recorded variable was significantly more frequent in the study group.
Reduction of body weight could therefore represent an important challenge in preventing the venous thromboembolism.
肥胖与静脉血栓栓塞是一个严重的医学问题。
对124例静脉血栓栓塞患者(研究组)研究了二者的相互关系,并与124例随机选取的住院患者对照组进行比较,对照组在年龄、性别和静脉血栓栓塞风险因素方面与研究组相匹配。
记录的变量有体重、动脉高血压、高甘油三酯血症、2型糖尿病或糖耐量受损情况。我们发现研究组肥胖患病率显著更高——40例对23例患者(38.5%对23%,p = 0.0283),且BMI显著更高(29.254对26.923,p = 0.002)。体重增加被发现是静脉血栓栓塞的唯一显著风险因素(比值比 = 2.507,p = 0.0026),而正常体重是唯一的保护因素(比值比 = 0.3989,p = 0.0026)。我们同样发现静脉血栓栓塞患病率随体重增加而显著上升(p = 0.020)。即使在无已知静脉血栓栓塞风险因素的患者中(n = 55),我们发现研究组体重增加(BMI > 25)的患病率显著更高(82.4%对61.2%,p = 0.0221)。研究组中没有其他记录变量的出现频率显著更高。
因此,减轻体重可能是预防静脉血栓栓塞的一项重要挑战。